Erythroblasts are a source of angiogenic factors

Blood

Volumn 97, Issue 7, 2001, Pages 1968-1974

  Tordjman, Rafaèle ^b   Delaire, Stéphanie ^b   Plouët, Jean ^b   Ting, Stephen ^b   Gaulard, Philippe ^b   Fichelson, Serge ^b   Roméo, Paul Henri ^b   Lemarchandel, Valérie ^a  

^a Institut Cochin   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; PLACENTA GROWTH FACTOR ANTIBODY; PLACENTAL GROWTH FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN ANTIBODY;

ANGIOGENESIS; ARTICLE; BONE MARROW; CELL DIFFERENTIATION; CELL MATURATION; CELL MEMBRANE PERMEABILITY; CELL MIGRATION; CIRCULATION; CONTROLLED STUDY; ENDOTHELIUM; ENDOTHELIUM CELL; ERYTHROBLAST; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0035313555     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.7.1968     Document Type: Article

References (43)

1. Three stages of erythropoietic progenitor cell differentiation distinguished by a number of physical and biologic properties
2. Mouse mutants provide new insights into the role of extracellular matrix in cell migration and differentiation
3. L'ilôt erythrobiastique, unité fonctionnelle de la moelle osseuse
4. The erythroblastic island: Past and future
5. Theoretical considerations on cell ensembles
6. How do normal and leukemic white blood cells egress from the bone marrow? Morphological facts and biochemical riddles
7. Neuropilin-1 is expressed on bone marrow stromal cells: A novel interaction with hematopoietic cells?
8. Neuropilin is a semaphorin III receptor
9. Neuropilin is a receptor for the axonal chemorepellent semaphorin III
10. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor
11. Neuropilin-1 is a placenta growth factor-2 receptor
12. The biology of vascular endothelial growth factor
13. Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants
14. Identification of a new endothelial cell growth factor receptor tyrosine kinase
15. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family
16. Glioblastoma growth inhibited in vivo by a dominant-negative FIk-1 mutant
17. Different signal transduction properties of KDR and Flt-1, two receptors for vascular endothelial growth tactor
18. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1
19. The vascular endothelial growth factor receptor Flt-1 mediates biological activities: Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis
20. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor
21. Heterodimers of placenta growth factor/vascular endothelial growth factor: Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR
22. Placenta growth factor: Identification and characterization of a novel isoform generated by RNA alternative splicing
23. A heparin-binding form of placenta growth factor (PIGF-2) is expressed in human umbilical vein endothelial cells and in placenta
24. Placenta growth factor: Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR
25. Placenta growth factor-1 is chemotactic, mitogenic and angiogenic
26. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice
27. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor
28. Purification and characterization of a naturally occurring vascular endothelial growth factor, placenta growth factor heterodimer
29. Purification, amplification and characterization of a population of human erythroid progenitors
30. Cell release of bioactive fibroblast growth factor 2 by exon 6-encoded sequence of vascular endothelial growth factor
31. Dendritic cell chemotaxis and transendothelial migration are induced by distinct chemokines and are regulated on maturation
32. Immunoenzymatic labeling of antibodies using immune complexes of alkaline phosphatase and monoclonal antialkaline phosphatase (APAAP complexes)
33. A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: Use of microwave oven heating to block antibody crossreactivity and retrieve antigens
34. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients
35. Constitutive production and thrombin-induced release of vascular endothelial growth by human megacaryocytes and platelets
36. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: Significance for VEGF measurements and cancer biology
37. An autocrine role for erythropoietin in mouse hematopoietic cell differentiation
38. Human hematopoietic progenitors express erythropoietin
39. Characterization of biologically active, platelet-dedved growth factor-like molecules produced by murine erythroid cells in vitro and in vivo
40. Regulated production of a pleiotropic cytokine-platelet-derived growth factor: By differentiating erythroid cells in vitro and in vivo
41. Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (PIGF) in regulating human haemopoietic cell growth
42. Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PIGF), are transcribed from a single gene of chromosome 14
43. Upregulation of the angiogenic factors PIGF, VEGF and their receptors (Flt-l, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization